文献速递胃肠外科围术期管理与 ERAS

镰状细胞病患儿术前输血与手术结局

Preoperative Transfusion and Surgical Outcomes for Children with Sickle Cell Disease.
PubMed 文献 · J Am Coll Surg · 2022-08-10

本研究基于NSQIP-Pediatrics数据库(2013至2019年),纳入术前红细胞压积低于30%的镰状细胞病患儿,比较术前输血与不输血在胆囊切除术、脾切除术或阑尾切除术后的结局。倾向性评分匹配后,两组30天因镰状细胞危象再入院率(5.8% vs 7.2%,p=0.80)和30天手术并发症发生率(10.8% vs 9.4%,p=0.84)无统计学显著差异。结论认为术前输血未与改善结局相关,需前瞻性研究以强化指南并减少不必要的围术期输血。

要点

  • 镰状细胞病患儿术前输血与不输血相比,30天危象再入院率无显著差异。
  • 匹配队列中两组30天手术并发症发生率无统计学显著差异。
  • 亚组分析未发现术前输血与镰状细胞危象或手术并发症风险改变相关。

核心结论

  • 镰状细胞病患儿接受半择期腹部手术时,术前输血与不输血相比未与改善结局相关。

研究设计与样本

  • 回顾性队列研究,查询NSQIP-Pediatrics数据库(2013至2019年),纳入357例镰状细胞病患儿,其中200例(56%)接受术前输血。
  • 采用倾向性评分匹配获得278例匹配队列(每组139例),比较术前输血与不输血组。

主要发现

  • 匹配队列中,术前输血组与不输血组30天因镰状细胞危象再入院率分别为5.8%和7.2%,p=0.80。
  • 匹配队列中,术前输血组与不输血组30天手术并发症发生率分别为10.8%和9.4%,p=0.84。
  • 按术前红细胞压积27.3%及以上或低于27.3%、ASA分级、切口分类和索引手术定义的亚组中,术前输血与不输血相比未与镰状细胞危象或手术并发症风险改变相关。

临床怎么用

  • 对于镰状细胞病患儿行半择期腹部手术,术前输血未显示明确获益,应避免不必要的围术期输血。

局限性

  • 本研究为回顾性数据库分析,结果需前瞻性研究验证以强化指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines recommending preoperative transfusion to a hemoglobin level of 9 to 10 g/dL for patients with sickle cell disease (SCD) are based on imperfect evidence. The benefit of preoperative transfusion in children specifically is not known. This study aimed to evaluate whether preoperative RBC transfusion is associated with different rates of sickle cell crisis and surgical complications, compared with no preoperative transfusion, among children with SCD undergoing common abdominal operations. STUDY DESIGN: The NSQIP-Pediatrics database (2013 to 2019) was queried. Patients who underwent cholecystectomy, splenectomy, or appendectomy with a preoperative Hct level of less than 30% were included. The primary outcome was 30-day readmission for sickle cell crisis. Secondary outcomes were 30-day surgical complications and hospital length of stay. Propensity score matching methods were used to obtain two statistically similar cohorts of patients comprised of those who were preoperatively transfused and those who were not. RESULTS: Among 357 SCD patients, 200 (56%) received preoperative transfusion. In the matched cohort of 278 patients (139 per group), there was no statistically significant difference in 30-day readmission for sickle cell crisis in the transfused and non-transfused groups (5.8% vs 7.2%, p = 0.80). The rate of 30-day surgical complications did not differ between matched groups (10.8% vs 9.4%, p = 0.84). Subgroups defined by presenting Hct levels of 27.3% or greater or less than 27.3%, American Society of Anesthesiologists classification, wound class, and index operation were not associated with an altered risk of sickle cell crisis or surgical complications after preoperative transfusion compared with no transfusion. CONCLUSIONS: Preoperative transfusion for children with SCD undergoing semi-elective abdominal operations was not associated with improved outcomes. Prospective investigation is warranted to strengthen guidelines and minimize unnecessary perioperative transfusions in this population.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Salvi PS, Solomon DG, Cowles RA, et al. Preoperative Transfusion and Surgical Outcomes for Children with Sickle Cell Disease. J Am Coll Surg. 2022. PMID: 35972175. doi:10.1097/XCS.0000000000000267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。